APA (7th ed.) Citation

GBJ, M., A, R., I, R., I, I., J, G., FJ, R., . . . RA, H. (2026). Assessment of LDL receptor-dependent lipid lowering therapies in patients with homozygous familial hypercholesterolemia according to functional genotype. Atherosclerosis, 414, 120646. https://doi.org/10.1016/j.atherosclerosis.2026.120646

Chicago Style (17th ed.) Citation

GBJ, Mancini, et al. "Assessment of LDL Receptor-dependent Lipid Lowering Therapies in Patients with Homozygous Familial Hypercholesterolemia According to Functional Genotype." Atherosclerosis 414 (2026): 120646. https://doi.org/10.1016/j.atherosclerosis.2026.120646.

MLA (9th ed.) Citation

GBJ, Mancini, et al. "Assessment of LDL Receptor-dependent Lipid Lowering Therapies in Patients with Homozygous Familial Hypercholesterolemia According to Functional Genotype." Atherosclerosis, vol. 414, 2026, p. 120646, https://doi.org/10.1016/j.atherosclerosis.2026.120646.